143 related articles for article (PubMed ID: 14972641)
1. A longitudinal study of antioxidant status in phenylketonuric patients.
Artuch R; Colomé C; Sierra C; Brandi N; Lambruschini N; Campistol J; Ugarte D; Vilaseca MA
Clin Biochem; 2004 Mar; 37(3):198-203. PubMed ID: 14972641
[TBL] [Abstract][Full Text] [Related]
2. Cognitive functions and the antioxidant system in phenylketonuric patients.
Gassió R; Artuch R; Vilaseca MA; Fusté E; Colome R; Campistol J
Neuropsychology; 2008 Jul; 22(4):426-31. PubMed ID: 18590354
[TBL] [Abstract][Full Text] [Related]
3. Poor zinc and selenium status in phenylketonuric children and adolescents in Brazil.
Barretto JR; Silva LR; Leite ME; Boa-Sorte N; Pimentel H; Purificação AC; Carvalho G; Fontes MI; Amorim T
Nutr Res; 2008 Mar; 28(3):208-11. PubMed ID: 19083409
[TBL] [Abstract][Full Text] [Related]
4. Selenium and antioxidant vitamin status of elderly German women.
Wolters M; Hermann S; Golf S; Katz N; Hahn A
Eur J Clin Nutr; 2006 Jan; 60(1):85-91. PubMed ID: 16118647
[TBL] [Abstract][Full Text] [Related]
5. Coenzyme Q10 in phenylketonuria and mevalonic aciduria.
Hargreaves IP
Mitochondrion; 2007 Jun; 7 Suppl():S175-80. PubMed ID: 17442628
[TBL] [Abstract][Full Text] [Related]
6. [Pathogenetic mechanisms in phenylketonuria: disorders affecting the metabolism of neurotransmitters and the antioxidant system].
Ormazábal A; Artuch R; Vilaseca MA; García-Cazorla A; Campistol J
Rev Neurol; 2004 Nov 16-30; 39(10):956-61. PubMed ID: 15573314
[TBL] [Abstract][Full Text] [Related]
7. Antioxidant and thyroid hormone status in selenium-deficient phenylketonuric and hyperphenylalaninemic patients.
van Bakel MM; Printzen G; Wermuth B; Wiesmann UN
Am J Clin Nutr; 2000 Oct; 72(4):976-81. PubMed ID: 11010940
[TBL] [Abstract][Full Text] [Related]
8. Age-related changes in plasma coenzyme Q10 concentrations and redox state in apparently healthy children and adults.
Miles MV; Horn PS; Tang PH; Morrison JA; Miles L; DeGrauw T; Pesce AJ
Clin Chim Acta; 2004 Sep; 347(1-2):139-44. PubMed ID: 15313151
[TBL] [Abstract][Full Text] [Related]
9. Lipophilic antioxidants in patients with phenylketonuria.
Colomé C; Artuch R; Vilaseca MA; Sierra C; Brandi N; Lambruschini N; Cambra FJ; Campistol J
Am J Clin Nutr; 2003 Jan; 77(1):185-8. PubMed ID: 12499340
[TBL] [Abstract][Full Text] [Related]
10. Ubiquinone-10 content in lymphocytes of phenylketonuric patients.
Colomé C; Artuch R; Vilaseca MA; Sierra C; Brandi N; Cambra FJ; Lambruschini N; Campistol J
Clin Biochem; 2002 Feb; 35(1):81-4. PubMed ID: 11937084
[TBL] [Abstract][Full Text] [Related]
11. Coenzyme Q10 (ubiquinol-10) supplementation improves oxidative imbalance in children with trisomy 21.
Miles MV; Patterson BJ; Chalfonte-Evans ML; Horn PS; Hickey FJ; Schapiro MB; Steele PE; Tang PH; Hotze SL
Pediatr Neurol; 2007 Dec; 37(6):398-403. PubMed ID: 18021919
[TBL] [Abstract][Full Text] [Related]
12. Enzymatic and non-enzymatic antioxidant status in stage (III) human oral squamous cell carcinoma and treated with radical radio therapy: influence of selenium supplementation.
Elango N; Samuel S; Chinnakkannu P
Clin Chim Acta; 2006 Nov; 373(1-2):92-8. PubMed ID: 16831410
[TBL] [Abstract][Full Text] [Related]
13. Longitudinal study of oxidative status in 312 cystic fibrosis patients in stable state and during bronchial exacerbation.
Lagrange-Puget M; Durieu I; Ecochard R; Abbas-Chorfa F; Drai J; Steghens JP; Pacheco Y; Vital-Durand D; Bellon G
Pediatr Pulmonol; 2004 Jul; 38(1):43-9. PubMed ID: 15170872
[TBL] [Abstract][Full Text] [Related]
14. Blood mononuclear cell coenzyme Q10 concentration and mitochondrial respiratory chain succinate cytochrome-c reductase activity in phenylketonuric patients.
Hargreaves IP; Heales SJ; Briddon A; Land JM; Lee PJ
J Inherit Metab Dis; 2002 Dec; 25(8):673-9. PubMed ID: 12705497
[TBL] [Abstract][Full Text] [Related]
15. Plasma phenylalanine is associated with decreased serum ubiquinone-10 concentrations in phenylketonuria.
Artuch R; Colomé C; Vilaseca MA; Sierra C; Cambra FJ; Lambruschini N; Campistol J
J Inherit Metab Dis; 2001 Jun; 24(3):359-66. PubMed ID: 11486901
[TBL] [Abstract][Full Text] [Related]
16. Long-term efficacy of 'ready-to-drink' protein substitute in phenylketonuria.
Gokmen-Ozel H; MacDonald A; Daly A; Hall K; Ryder L; Chakrapani A
J Hum Nutr Diet; 2009 Oct; 22(5):422-7. PubMed ID: 19743980
[TBL] [Abstract][Full Text] [Related]
17. Clinical and nutritional evaluation of phenylketonuric patients on tetrahydrobiopterin monotherapy.
Lambruschini N; Pérez-Dueñas B; Vilaseca MA; Mas A; Artuch R; Gassió R; Gómez L; Gutiérrez A; Campistol J
Mol Genet Metab; 2005 Dec; 86 Suppl 1():S54-60. PubMed ID: 16040265
[TBL] [Abstract][Full Text] [Related]
18. [Coenzyme q10 in childhood: detection methods, reference values and disease-related changes in the coenzyme q10 status].
Menke T
Georgian Med News; 2008 Mar; (156):24-32. PubMed ID: 18403806
[TBL] [Abstract][Full Text] [Related]
19. Levels of selenium, zinc, copper, and antioxidant enzyme activity in patients with leukemia.
Zuo XL; Chen JM; Zhou X; Li XZ; Mei GY
Biol Trace Elem Res; 2006; 114(1-3):41-53. PubMed ID: 17205986
[TBL] [Abstract][Full Text] [Related]
20. Decreased serum ubiquinone-10 concentrations in phenylketonuria.
Artuch R; Vilaseca MA; Moreno J; Lambruschini N; Cambra FJ; Campistol J
Am J Clin Nutr; 1999 Nov; 70(5):892-5. PubMed ID: 10539751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
